Tatiana Steiler is a forward-thinking executive with international leadership experience across the healthcare and manufacturing sectors. She has held senior roles at global organizations including Novartis, Terumo Blood and Cell Technologies, and Danone, where she consistently led strategic transformation, digital innovation, and sustainable growth.
Her expertise spans business agility, operational excellence, and data- and ROI-driven leadership. She has a proven track record of launching digital platforms, omnichannel strategies, and value-based operating models—delivering measurable impact in market expansion, cross-functional launch excellence, and talent development.
Tatiana holds a PhD in medicine from the Karolinska Institute and Sorbonne University, complemented by executive education from IESE Business School. This unique blend of scientific depth and commercial acumen enables her to navigate complex challenges with a creative, analytical, and human-centered mindset. Fluent in three languages, she thrives in diverse, multicultural environments.
A published biomedical researcher in journals such as Cell and Diabetes, and a named inventor in functional food innovation, Tatiana brings a deep commitment to advancing science with real-world impact. She has also shaped healthcare policy, fostered interdisciplinary collaboration, and accelerated access to innovation, demonstrating her ability to drive systemic change.
Her nonprofit work extends from mentoring future female leaders in technology and innovation through the Women in AI community to collaborating with youth-focused organizations on innovative funding models that drive meaningful societal change.
Tatiana approaches complex challenges with a human-centered, results-driven mindset—committed to sustainable growth, value creation, and empowering people to thrive.
